Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
938.6 USD | +0.10% | +6.39% | +6.99% |
May. 02 | Morgan Stanley Raises Price Target on Regeneron Pharmaceuticals to $1,183 From $1,177 | MT |
May. 02 | Piper Sandler Adjusts Regeneron Pharmaceuticals' Price Target to $1,000.25 From $1,016 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.99% | 101B | |
-2.00% | 103B | |
+4.51% | 23.07B | |
-11.55% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.98% | 16.94B | |
+6.27% | 14.07B | |
+36.67% | 12.35B | |
-22.82% | 8.36B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating